[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-352920-105":59,"doc-detail-352920-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","tumor-microenvironment-and-key-signaling-pathways-in-breast-cancer-progression-and-therapy-resistance-a-review","Tumor microenvironment and key signaling pathways in breast cancer progression and therapy resistance - A review","","Breast cancer progression is shaped by reciprocal interactions between tumor-intrinsic alterations and the tumor microenvironment (TME), which comprises fibroblasts, immune and endothelial cells, adipocytes, extracellular matrix elements, soluble mediators, and extracellular vesicles. This review integrates recent basic and translational findings on how TME-derived signals activate dysregulated pathways such as PI3K/AKT/mTOR, TGF-β/SMAD, JAK/STAT, MAPK/ERK, Wnt/β-catenin, Notch, YAP/TAZ, and NF-κB. These networks drive invasion, angiogenesis, hypoxia adaptation, EMT, immune evasion, stemness, and therapy resistance through feedback sustaining plasticity and drug-tolerant states, and outlines emerging therapies including normalization, combination immunotherapy, targeted inhibitors, and nanodelivery.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/tumor-microenvironment-and-key-signaling-pathways-in-breast-cancer-progression-and-therapy-resistance-a-review/352920/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/tumor-microenvironment-and-key-signaling-pathways-in-breast-cancer-progression-and-therapy-resistance-a-review/352920.png","ImageObject",300,407,{"name":92,"@type":93},"Nguyễn Văn Học","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-19","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the role of the tumor microenvironment (TME) in breast cancer progression?","Question",{"text":112,"@type":113},"The TME provides a complex ecosystem that reciprocally interacts with tumor cells, influencing disease outcomes and therapeutic responses through cellular components and mediators.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which signaling pathways are highlighted as being activated by TME-derived signals?",{"text":117,"@type":113},"The review emphasizes dysregulated pathways including PI3K/AKT/mTOR, TGF-β/SMAD, JAK/STAT, MAPK/ERK, Wnt/β-catenin, Notch, YAP/TAZ, and NF-κB.",{"name":119,"@type":110,"acceptedAnswer":120},"How do TME–signaling interactions contribute to therapy resistance?",{"text":121,"@type":113},"Convergent findings indicate feedback between tumor cells and the TME sustains plasticity and generates drug-tolerant states, alongside processes such as immune evasion and EMT.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},352920,1790488989,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1374402739827,"https://ap-avatar.wpscdn.com/avatar/14000c97e7351f1a627?x-image-process=image/resize,m_fixed,w_180,h_180&k=1787885694763230660","REVIEW  \nTumor microenvironment and key signaling pathways in breast cancer progression and therapy resistance: A review  \nRui Li1, Yujing Wang1, and Min Xie2 􀀃  \nBreast cancer progression is in􀀎uenced not only by intrinsic tumor alterations but also by reciprocal interactions with the tumor microenvironment (TME), a complex ecosystem comprising 􀀏broblasts, immune and endothelial cells, adipocytes, extracellular matrix components, soluble mediators, and extracellular vesicles. This review synthesizes recent basic and translational research on how TME-derived signals activate dysregulated signaling pathways, including the phosphoinositide3-kinase/protein kinase B/mechanistic target of rapamycin (PI3K/AKT/mTOR), transforming growth factor beta/SMAD (TGF-β/SMAD), Janus kinase/signal transducer and activator of transcription (JAK/STAT), mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK), Wingless-related integration site/beta-catenin (Wnt/β-catenin), Notch, Yes-associated protein/transcriptional co-activator with PDZ-binding motif (YAP/TAZ), and nuclear factor kappa B (NF-κB). These pathways promote key processes such as invasion, angiogenesis, adaptation to hypoxia, epithelial–mesenchymal transition, immune evasion, cancer stemness, and therapy resistance. We emphasize convergent 􀀏ndings that indicate the feedback loop between tumor cells and the TME sustains plasticity and drug-tolerant states. Additionally, we summarize emerging therapeutic strategies, including stromal and extracellular matrix normalization, immunotherapy combinations, pathway-targeted inhibitors, and nanotechnology-enabled drug delivery. A comprehensive understanding of TME–signaling crosstalk is crucial for overcoming therapeutic resistance in breast cancer.  \nKeywords: Breast cancer, tumor microenvironment, cell signaling.  \nIntroduction  \nBreast cancer represents a signi􀀏cant public health challenge, accounting for a substantial proportion of cancer-related mortalities globally [1] . This disease is highly heterogeneous and is categorized into distinct subtypes—namely, estrogen receptor (ER)/progesterone receptor (PR)-positive, HER2-positive, and triple-negative breast cancer (TNBC)—based on speci􀀏c molecular expression patterns, including the ampli􀀏cation of ER, PR, and human epidermal growth factor receptor 2 (HER2) [2] . Traditionally, clinical cancer researchers have focused on cancer cell experiments that examine cellular metabolism, proliferation mechanisms, genetic alterations, and responses tomonotherapy interventions [3, 4] . However, it is increasingly recognized that tumor biology cannot be fully understood through a singular approach, as it undergoes dynamic changes within the complex tumor microenvironment (TME) [5] . The TME encompasses the ecosystem surrounding tumor cells, comprising cellular components such as stromal cells, immune in􀀏ltrates, the extracellular matrix, vascular and lymphatic networks, anda diverse array ofnon-cellular mediators, includ-  \ning growth factors, cytokines, metabolic byproducts, and extracellular vesicles [6] .  \nIn breast cancer, the spatial arrangement, composition, and functional interactions between the cellular and non-cellular components of the TME signi􀀏cantly in􀀎uence disease outcomes and therapeutic responses. For instance, the molecular signaling networks within tumor cells, signal transduction pathways, and intercellular interactions are increasingly recognized as critical mediatorsofTME-drivene􀀍ects[6]. Within the TME, alterations in signaling cascades, such as phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin (PI3K/AKT/mTOR), mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK), transforming growth factor-β-SMAD (TGF-β-SMAD), wingless-related integration site/β-Catenin (Wnt/β-Catenin), and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), which are mechanistically signi􀀏cant in tumor cells, are fundament","cbCaigbDGLiQO7gG","https://ap.wps.com/l/cbCaigbDGLiQO7gG","pdf",1997708,15,"English","# Introduction\n## Breast cancer heterogeneity and subtypes\n## Role and composition of the tumor microenvironment (TME)\n# TME-driven signaling pathways\n## PI3K/AKT/mTOR\n## TGF-β/SMAD\n## JAK/STAT\n## MAPK/ERK\n## Wnt/β-catenin\n## Notch\n## YAP/TAZ\n## NF-κB\n# Functional consequences in tumor progression\n## Invasion, angiogenesis, and hypoxia adaptation\n## Epithelial–mesenchymal transition (EMT)\n## Immune evasion and cancer stemness\n## Therapy resistance\n# Feedback loops and plasticity\n## Tumor cell–TME sustaining drug-tolerant states\n# Emerging therapeutic strategies\n## Stromal and extracellular matrix normalization\n## Immunotherapy combinations\n## Pathway-targeted inhibitors\n## Nanotechnology-enabled drug delivery\n# Conclusion\n## Importance of TME–signaling crosstalk","[{\"question\":\"What is the role of the tumor microenvironment (TME) in breast cancer progression?\",\"answer\":\"The TME provides a complex ecosystem that reciprocally interacts with tumor cells, influencing disease outcomes and therapeutic responses through cellular components and mediators.\"},{\"question\":\"Which signaling pathways are highlighted as being activated by TME-derived signals?\",\"answer\":\"The review emphasizes dysregulated pathways including PI3K/AKT/mTOR, TGF-β/SMAD, JAK/STAT, MAPK/ERK, Wnt/β-catenin, Notch, YAP/TAZ, and NF-κB.\"},{\"question\":\"How do TME–signaling interactions contribute to therapy resistance?\",\"answer\":\"Convergent findings indicate feedback between tumor cells and the TME sustains plasticity and generates drug-tolerant states, alongside processes such as immune evasion and EMT.\"}]","Tumor microenvironment and key signaling pathways in breast cancer progression and therapy resistance - A review | PDF",1790101988,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b4c375d53980aa90b23f976fc7a225cd.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6bf1da46bc5d003e28dc9e0ba9fe86dd.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4827294c8e094be9e8bf11fe4e4d9b36.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3f73f017131267a9899ee3a007469da2.webp",980,1268]